etidronate has been researched along with Osteitis Fibrosa Cystica in 2 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Osteitis Fibrosa Cystica: A fibrous degeneration, cyst formation, and the presence of fibrous nodules in bone, usually due to HYPERPARATHYROIDISM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "No publications have reported on osteomalacia in patients receiving intermittent cyclical therapy with etidronate (a bisphosphonate) and undergoing long-term hemodialysis (HD)." | 4.02 | Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis. ( Hatano, M; Hirota, Y; Hoshino, J; Isawa, K; Kitajima, I; Nakamura, M; Sawa, N; Ubara, Y; Yamamoto, S, 2021) |
| "Radiographic changes of osteitis fibrosa cystica developed in 1 child and bone biopsy in 2 children showed defective osteoid mineralisation." | 1.26 | Diphosphonate therapy in nephrocalcinosis. ( McCredie, DA; Powell, HR; Rotenberg, E, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, M | 1 |
| Kitajima, I | 1 |
| Yamamoto, S | 1 |
| Nakamura, M | 1 |
| Isawa, K | 1 |
| Hirota, Y | 1 |
| Hoshino, J | 1 |
| Sawa, N | 1 |
| Ubara, Y | 1 |
| McCredie, DA | 1 |
| Powell, HR | 1 |
| Rotenberg, E | 1 |
2 other studies available for etidronate and Osteitis Fibrosa Cystica
| Article | Year |
|---|---|
Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis.
Topics: Bone and Bones; Bone Density Conservation Agents; Calcitriol; Cholecalciferol; Etidronic Acid; Human | 2021 |
Diphosphonate therapy in nephrocalcinosis.
Topics: Bartter Syndrome; Body Height; Bone and Bones; Calcium; Child; Diet; Drug Evaluation; Etidronic Acid | 1976 |